CE Marking for medical devices


The medical device industry has become an important cornerstone of the Irish economy with over 25,000 workers and exports in excess of €6 billion a year.

Medical devices are rigorously regulated by EU Directives covering health, safety and environmental protection. Medical devices complying with the essential requirements of these Directives are entitled to display the CE Marking, which allows the device to be sold anywhere across the European Union and European Free Trade Area.

 

NSAI – the Notified Body

The Irish Medicines Board is the Competent Authority in Ireland for the implementation of EU and national legislation relating to medical devices, medicines and blood products.

The Board has in turn approved NSAI as the Notified Body to carry out the conformity assessment procedures to ensure compliance with a number of Medical Directives.

 


NSAI’s responsibilities

NSAI has extensive responsibilities for the quality of a range of products covered by the following Medical Device Directives (or some of their annexes as specified):
 
In addition to our responsibility for these Directives, NSAI has specific expertise in providing CE Markings for drug-device combination products.

 

Online application forms

To apply to have a medical device reviewed for CE Marking, or for a three-year renewal of your CE Marking, under the MDD or the AIMD, download the NSAI Medical Devices Application Review Form.

To apply to have a In Vitro Diagnostic medical device reviewed for CE Marking, or for a three-year renewal of your CE Marking, download the IVD Application Review form.

To notify us of any changes in your device or its use, whether substantial or non-substantial, download the NSAI Medical Devices Notification of Substantial/Non-Substantial Change Form for MDD's or AIMD's or Application Review Substantial and Non-substantial Changes for IVD's.

RH Rev. 1.0

Legal Policy | Accessibility | Site Map | External Links | Contact Us

This site is best viewed in Internet Explorer 7.0+, Firefox 3.0+ and Chrome 3.0+ esolution created by Elucidate - Web strategy